20 November 2015 - Deborah Wilkes
Archived
Australia's Therapeutic Goods Administration (TGA) has deferred its decision on the proposed reverse-switch of all non-prescription medicines containing codeine to prescription status. The regulatory agency, which had intended to make a final decision in November 2015, now says no decision will be made before 23 June 2016.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.